← All Burning Rock Biotech LTD filings

Burning Rock Biotech LTD 20-F annual reports

The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.

NASDAQ
BNR
Burning Rock Biotech LTD
20-F: Burning Rock Biotech Reports Reduced Net Loss in 2025
Burning Rock Biotech Limited announced its financial results for the fiscal year ended December 31, 2025, reporting a significant reduction in net loss compared to the previous year.
NASDAQ
BNR
Burning Rock Biotech LTD
20-F: Burning Rock Biotech Navigates Regulatory Landscape with Key Agreement Amendments
Burning Rock Biotech amends key agreements to align with PRC regulations and facilitate business operations.
NASDAQ
BNR
Burning Rock Biotech LTD
20-F/A: Burning Rock Biotech Amends 20-F Filing to Include Revised Officer Certifications
Burning Rock Biotech has filed an amendment to its annual report on Form 20-F to include revised officer certifications in response to SEC comments.
NASDAQ
BNR
Burning Rock Biotech LTD
20-F: Burning Rock Biotech Limited Files Form 20-F for Fiscal Year Ended December 31, 2023
Burning Rock Biotech Limited's Form 20-F filing details the company's financial performance, operational structure, and associated risks for the fiscal year ended December 31, 2023.